LHC Group - common stock (LHCG): Price and Financial Metrics
LHC Group - common stock (LHCG)
Today's Latest Price: $199.91 USD
Updated Jan 27 3:43pm
Add LHCG to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 77 in Medical - Services
See all "A" rated Strong Buy stocks
LHCG Stock Summary
- LHCG's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 4,963.02 -- higher than 99.14% of US-listed equities with positive expected earnings growth.
- Of note is the ratio of LHC Group Inc's sales and general administrative expense to its total operating expenses; 87.56% of US stocks have a lower such ratio.
- With a year-over-year growth in debt of -63.2%, LHC Group Inc's debt growth rate surpasses just 4.51% of about US stocks.
- Stocks that are quantitatively similar to LHCG, based on their financial statements, market capitalization, and price volatility, are SKY, WSO, BMI, NUS, and DECK.
- LHCG's SEC filings can be seen here. And to visit LHC Group Inc's official web site, go to www.lhcgroup.com.
LHCG Stock Price Chart Interactive Chart >
LHCG Price/Volume Stats
| Current price | $199.91 | 52-week high | $236.81 |
| Prev. close | $215.90 | 52-week low | $100.00 |
| Day low | $198.60 | Volume | 219,842 |
| Day high | $212.30 | Avg. volume | 157,069 |
| 50-day MA | $208.93 | Dividend yield | N/A |
| 200-day MA | $190.54 | Market Cap | 6.32B |
LHC Group - common stock (LHCG) Company Bio
LHC Group is a national provider of post-acute healthcare services, providing quality, cost-effective healthcare to patients within the comfort and privacy of their home or place of residence. LHC Group provides a comprehensive array of healthcare services through home health, hospice and community-based services and provides inpatient care through long-term acute care hospitals. The company was founded in 1994 and is based in Lafayette, Louisiana.
LHCG Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $199.91 | $715.86 | 232% |
We started the process of determining a valid price forecast for LHC Group Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that LHC Group Inc ranked in the 75th percentile in terms of potential gain offered. Specifically, our DCF analysis implies the stock is trading below its fair value by an estimated 233.17%. The most interesting components of our discounted cash flow analysis for LHC Group Inc ended up being:
- The stock's equity weight, or the proportion of capital from equity relative to debt, is 98. Notably, its equity weight is greater than 83.4% of US equities in the Healthcare sector yielding a positive free cash flow.
- The business' balance sheet suggests that 2% of the company's capital is sourced from debt; this is greater than only 9.14% of the free cash flow producing stocks we're observing.
- LHCG's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 3%; for context, that number is higher than 50.03% of tickers in our DCF set.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | 225% |
| 1% | 228% |
| 2% | 232% |
| 3% | 235% |
| 4% | 238% |
| 5% | 241% |
SUPN, VTRS, CI, UHS, and SUWN can be thought of as valuation peers to LHCG, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.
Loading social stream, please wait...